  The sustainable use of multicomponent treatments such as combination
therapies, combination vaccines/chemicals, and plants carrying multigenic
resistance requires an understanding of how their population-wide deployment
affects the speed of the pathogen adaptation. Here, we develop a stochastic
model describing the emergence of a mutant pathogen and its dynamics in a
heterogeneous host population split into various types by the management
strategy. Based on a multi-type Markov birth and death process, the model can
be used to provide a basic understanding of how the life-cycle parameters of
the pathogen population, and the controllable parameters of a management
strategy affect the speed at which a pathogen adapts to a multicomponent
treatment. Our results reveal the importance of coupling stochastic mutation
and migration processes, and illustrate how their stochasticity can alter our
view of the principles of managing pathogen adaptive dynamics at the population
level. In particular, we identify the growth and migration rates that allow
pathogens to adapt to a multicomponent treatment even if it is deployed on only
small proportions of the host. In contrast to the accepted view, our model
suggests that treatment durability should not systematically be identified with
mutation cost. We show also that associating a multicomponent treatment with
defeated monocomponent treatments can be more durable than associating it with
intermediate treatments including only some of the components. We conclude that
the explicit modelling of stochastic processes underlying evolutionary dynamics
could help to elucidate the principles of the sustainable use of multicomponent
treatments in population-wide management strategies intended to impede the
evolution of harmful populations.
